NME
AMGN icon

Notis-McConarty Edward’s Amgen AMGN Stock Holding History

Notis-McConarty Edward’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4M Hold
3,986
– – 0.7% 35
2025
Q4 		$1.3M Hold
3,986
– – 0.61% 39
2025
Q3 		$1.12M Sell
3,986
-21
-0.5% -$6.09K 0.52% 42
2025
Q2 		$1.12M Sell
4,007
-100
-2% -$28.3K 0.55% 43
2025
Q1 		$1.28M Buy
4,107
+42
+1% +$12.4K 0.66% 35
2024
Q4 		$1.06M Sell
4,065
-10
-0.2% -$2.97K 0.51% 42
2024
Q3 		$1.31M Hold
4,075
– – 0.59% 41
2024
Q2 		$1.27M Sell
4,075
-265
-6% -$77.9K 0.5% 47
2024
Q1 		$1.23M Sell
4,340
-743
-15% -$217K 0.49% 46
2023
Q4 		$1.46M Sell
5,083
-600
-11% -$163K 0.58% 44
2023
Q3 		$1.53M Sell
5,683
-845
-13% -$211K 0.62% 41
2023
Q2 		$1.45M Hold
6,528
– – 0.55% 46
2023
Q1 		$1.58M Sell
6,528
-15
-0.2% -$3.68K 0.63% 43
2022
Q4 		$1.72M Sell
6,543
-200
-3% -$53.6K 0.72% 39
2022
Q3 		$1.52M Sell
6,743
-350
-5% -$84.8K 0.68% 43
2022
Q2 		$1.73M Sell
7,093
-730
-9% -$179K 0.72% 43
2022
Q1 		$1.89M Sell
7,823
-30
-0.4% -$6.89K 0.68% 44
2021
Q4 		$1.77M Hold
7,853
– – 0.59% 48
2021
Q3 		$1.67M Sell
7,853
-1,000
-11% -$230K 0.61% 44
2021
Q2 		$2.16M Sell
8,853
-912
-9% -$224K 0.8% 42
2021
Q1 		$2.43M Buy
9,765
+500
+5% +$119K 0.95% 37
2020
Q4 		$2.13M Sell
9,265
-700
-7% -$161K 0.87% 37
2020
Q3 		$2.53M Sell
9,965
-110
-1% -$27.3K 1.11% 32
2020
Q2 		$2.38M Sell
10,075
-565
-5% -$129K 1.11% 33
2020
Q1 		$2.16M Sell
10,640
-340
-3% -$74.3K 1.19% 29
2019
Q4 		$2.65M Sell
10,980
-375
-3% -$82.7K 1.18% 28
2019
Q3 		$2.2M Sell
11,355
-362
-3% -$69.5K 1.03% 33
2019
Q2 		$2.16M Sell
11,717
-240
-2% -$43K 1.02% 31
2019
Q1 		$2.27M Hold
11,957
– – 1.1% 29
2018
Q4 		$2.33M Sell
11,957
-350
-3% -$68.3K 1.28% 26
2018
Q3 		$2.55M Sell
12,307
-325
-3% -$64K 1.36% 26
2018
Q2 		$2.33M Sell
12,632
-200
-2% -$35.4K 1.38% 26
2018
Q1 		$2.19M Sell
12,832
-425
-3% -$78K 1.31% 25
2017
Q4 		$2.31M Sell
13,257
-710
-5% -$126K 1.32% 25
2017
Q3 		$2.6M Sell
13,967
-100
-0.7% -$17.7K 1.63% 24
2017
Q2 		$2.42M Sell
14,067
-225
-2% -$36.6K 1.57% 22
2017
Q1 		$2.34M Sell
14,292
-265
-2% -$44K 1.54% 24
2016
Q4 		$2.13M Hold
14,557
– – 1.47% 24
2016
Q3 		$2.43M Sell
14,557
-25
-0.2% -$4.23K 1.66% 22
2016
Q2 		$2.22M Hold
14,582
– – 1.56% 23
2016
Q1 		$2.19M Hold
14,582
– – 1.55% 23
2015
Q4 		$2.37M Hold
14,582
– – 1.7% 21
2015
Q3 		$2.02M Sell
14,582
-69
-0.5% -$10.9K 1.51% 26
2015
Q2 		$2.25M Sell
14,651
-335
-2% -$53.7K 1.52% 26
2015
Q1 		$2.4M Sell
14,986
-200
-1% -$31.5K 1.66% 24
2014
Q4 		$2.42M Hold
15,186
– – 1.65% 25
2014
Q3 		$2.13M Sell
15,186
-535
-3% -$69.8K 1.5% 27
2014
Q2 		$1.86M Hold
15,721
– – 1.23% 29
2014
Q1 		$1.94M Sell
15,721
-200
-1% -$24.3K 1.35% 27
2013
Q4 		$1.82M Buy
+15,921
New +$1.81M 1.27% 26

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Notis-McConarty Edward's AMGN Position: Q1 2026 in Review

Notis-McConarty Edward held its Amgen (AMGN) position steady in Q1 2026 at 3,986 shares worth $1.4M. The position accounts for 0.7% of the portfolio, ranked #35.

Notis-McConarty Edward first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.65M in Q4 2019. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Notis-McConarty Edward held 3,986 shares of Amgen worth $1.4M as of Q1 2026.
  • Notis-McConarty Edward left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.7% of Notis-McConarty Edward's portfolio in Q1 2026, its #35 holding.
  • Notis-McConarty Edward first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
  • Notis-McConarty Edward's Amgen position peaked at $2.65M in Q4 2019.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Notis-McConarty Edward's 13F filing for Q1 2026, filed 8 May 2026.